コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 a task that yields quantitative measures of body image.
2 nistered to enhance athletic performance and body image.
3 y in a distributed neural network underlying body image.
4 after radiotherapy, but with no detriment to body image.
5 ved in all psychosocial subscales except for body image.
6 nificant change scores were observed only in body image.
7 with relationships, sexual functioning, and body image.
8 tion but received mastectomy had the poorest body image.
9 eight, fear of gaining weight, and distorted body image.
10 disordered eating in relation to weight and body image.
11 argeting autoimmunity to correcting abnormal body image.
12 ctivity, healthy eating, and self-esteem and body image.
13 treatments that intervene to manipulate the body image.
14 h included quality of life, self-esteem, and body image.
15 bined with organ-based analysis of the whole-body images.
16 ar vertebrae in anterior and posterior whole-body images.
17 es were obtained; this was followed by whole-body images.
18 -410 MBq anti-(18)F-FACBC followed by static body images.
19 ms for quantitative, three-dimensional whole-body images.
20 pened animal confirmed the identity of whole-body images.
21 es, with a strong selectivity for individual body images.
22 e neurons responded to a small proportion of body images.
23 ate tissue well, IFPs are suitable for whole-body imaging.
24 or typical scan lengths at clinical head and body imaging.
25 regression of xenografts visualized by whole-body imaging.
26 alized directly by gamma-scintigraphic whole-body imaging.
27 ve of clinical studies, in particular, whole-body imaging.
28 kanamycin treatment were visualized by whole-body imaging.
29 er gavage was followed in real-time by whole-body imaging.
30 over a 10-day period as determined by whole-body imaging.
31 ity of the clinical PET/CT scanner for whole-body imaging.
32 tissues and cells and to non-invasive whole-body imaging.
33 unknown areas of disease when used for full-body imaging.
34 p radiolabelling allowed complementary whole-body imaging.
35 the question of how the brain constructs a 'body image.'
36 ical health (0.94), emotional health (0.94), body image (0.89), pain (0.92), planning (0.93), fatigue
38 e with acne, the highest-scored domains were body image (15.66), appearance (14.96), life satisfactio
39 who received breast conservation had better body image 2 years after treatment than women who had ma
40 of these technologic advances include whole-body imaging, 3-dimensional imaging, new scintillator ma
43 were a validated cosmesis (3-24 points) and body image (5-20 points) score after 3 and 12 months.
44 nctional scales, APR patients reported worse body image (70.3 vs 77.0, P = 0.0005) at 1 year than did
46 ences in tissue types in, for example, whole-body imaging, a set of tissue homogenates of different t
48 nsgenic (luciferase) reporter mice and whole-body imaging, allowing noninvasive quantification of tra
50 more emphasis in society is placed on one's body image and appearance there has been an increase in
52 most domains of quality of life, as well as body image and depressive symptoms, within the first yea
54 wn about the impact of surgical treatment on body image and health outcomes in older breast cancer pa
55 ntary explores the potential implications of body image and its distortions for the insurance hypothe
56 tion has the potential to improve a person's body image and quality of life but has important risks.
57 stectomy breast reconstruction is to restore body image and quality-of-life after mastectomy, but rem
59 image in female breast cancer survivors, the Body Image and Relationships Scale (BIRS), was developed
60 tus (Breast Cancer Treatment Outcome Scale); body image and sexuality (Body Image Scale); and perceiv
61 treatment preferences predicts posttreatment body image and whether body image, in turn, affects ment
63 cted in humans and model organisms including body images and whole-genome gene expression profiles.
64 ion of human tumor-host interaction by whole-body imaging and at the cellular level in fresh and froz
65 sualizes the tumor-host interaction by whole-body imaging and at the cellular level in fresh tissues,
68 e to a neurologically determined disorder of body-image and bodyego induced by peripheral injury.
69 rted for the areas of family dysfunction and body image, and few studies have been published in the a
72 ould be explained by changes in self-esteem, body image, and intrusive thoughts about the illness.
73 has salutary effects on sexual functioning, body image, and menopausal symptoms in BCSs with a sexua
76 (PCS), symptom resolution and satisfaction, body image, and sexual functioning, as well as other asp
77 on of the body external appearance, i.e. the body image, and suggest the existence of two functionall
78 two-photon microscopy and non-invasive whole-body imaging, and can be used to study microbial coloniz
79 Tumors are tracked in living mice by whole-body imaging, and macrometastases or micrometastases are
80 tectural affordances, we used a mobile brain/body imaging approach recording brain activity synchroni
81 mechanisms integrating sensory signals into body image are altered in subclinical and clinical EDs.
83 chnological developments in mobile brain and body imaging are enabling new frontiers of real-world ne
84 findings highlight body image investment and body image as important psychological factors that may i
85 body mass index, body image investment, and body image as statistically significantly associated wit
86 a top-down approach using noninvasive whole-body imaging as a guide for in-depth characterization of
87 r Physical, Role and Social Functioning, and Body Image, as well as for Mobility, Self-care, and Pain
88 ble covalently bound product C3d by external body imaging, as a marker of complement activation in he
90 ty of life (assessed via Short-Form 12), and body image (assessed with the Spanish Body Image Scale).
91 PECT/CT images were obtained after the whole-body images at 2 and 24 h if there was relevant uptake i
93 -MFBG intravenously followed by serial whole-body imaging at 0.5-1, 1-2, and 3-4 after injection.
96 urse of treatment, noninvasive optical whole-body imaging based on brilliant red fluorescent protein
97 cantly better up to 24 months (P = .031) and body image better at 3, 24, and 36 months (P <= .01) for
98 tter physical functioning (P = .006), better body image (BI; P < .001), less pain (P < .001) and its
99 TV50)), SUV(max), SUV(mean), and other whole-body imaging biomarkers were calculated for each patient
100 etrosal sinus sampling, and adrenal or whole-body imaging can help identify tumor sources of hypercor
103 rders, psychosexual dysfunction and negative body image, collectively contributing to diminished heal
104 al-Axial, Spine, Hematologic Diseases, Whole-Body Imaging, Comparative Studies Supplemental material
105 SPLC-group showed superior mean cosmesis and body image compared with the 4PLC-group at 12-weeks (21
106 ients with ARVD/C had substantially elevated body image concerns (Florida Patient Acceptance Survey s
109 he FPAS showed that patients had significant body image concerns, but return to function and device-r
111 al treatment of eating disorders and related body-image concerns in middle-aged and elderly women.
114 We hypothesized that conduct disorder and body-image concerns would be major risk factors for subs
115 l and psychological aspects of sexuality and body image, CSA was not a significant predictor of physi
116 thyroid carcinoma, and on radioiodine total-body imaging demonstrated focal, lower-right chest uptak
119 at clinicians should be alert for eating and body-image disorder even in women well beyond the younge
121 ntral body fat deposition is associated with body image dissatisfaction and suggest that it may repre
122 ages has been linked to eating disorders and body image dissatisfaction in men, women, and children.
124 be anhedonic, hunger and pain are muted, and body-image distortion obscures wasting, which together f
125 athology characterized by restricted eating, body image distortions and impaired socio-cognitive abil
128 survivors experience clinically significant body image distress (BID), a psychosocial morbidity that
130 anxiety, fatigue and sleep, pain, pruritus, body image distress, sexual function, work disability, h
135 ), as increased levels of depersonalization, body image disturbances, and reduced sensitivity to phys
137 of self-esteem, attitudes toward male roles, body image, eating-related attitudes and behaviors, and
138 ention group reported greater improvement in body image (EST2 = .45; P = .009) and fewer menopausal s
139 te the feasibility of using mobile brain and body imaging even in very extreme conditions (race car d
140 use of avoidant coping strategies, negative body image, feelings of fear and uncertainty in relation
141 Four observers (experienced sonologist, body imaging fellow, 1st-year radiology resident, and pr
145 times in the Patlak images than in the whole-body images for (68)Ga-DOTATOC and (68)Ga-DOTATATE, resp
147 the parametric Ki images compared with whole-body images for both (68)Ga-DOTATOC and (68)Ga DOTATATE.
148 ased with increasing scan rate, useful whole-body images for propranolol were obtained from the tissu
150 hese results show the potential use of whole-body imaging for receptor status assessment, particularl
154 st a stronger influence of visual signals on body image in individuals with eating disorders (EDs) th
161 redicts posttreatment body image and whether body image, in turn, affects mental health in older wome
162 eralized estimating equations, we found that body image, in turn, predicted 2-year mental health.
163 recurrence support performing regular whole-body imaging initially every 6 to 12 months and continui
164 t, including sexual identity), their bodies (body image), initiating intimate and emotional relations
165 h cancer, aiming to improve sexual response, body image, intimacy and relationship issues, and overal
167 Our analyses identified body mass index, body image investment, and body image as statistically s
169 s of sexual satisfaction, orgasm and patient body image is essential, however, to allow a comparison
171 se findings provide new insight into how the body image is maintained, and may prove useful in treatm
172 of their body, suggesting that the conscious body image is not fully determined by immediate sensory
173 sting revealed that the encoding capacity of body images is higher than that of characters, faces, an
174 valently used molecular imaging technique in body imaging is currently fluorine 18 fluorodeoxyglucose
176 l comorbidities, patients with HS often face body image issues and emotional distress that may increa
178 with sex life, feeling sexually attractive, body image, marital satisfaction, quality of life, medic
180 , despite differing SCI levels, imply that a body image may be maintained despite chronic sensory and
181 relationship intimacy (primary outcomes) and body image, menopausal symptoms, marital functioning, ps
182 eighted Imaging, Radionuclide Therapy, Whole-Body Imaging, Metastases, Tumor Response, Treatment Effe
183 d therefore EUS is usually performed after a body imaging modality such as computed tomography or pos
185 righter, red-shifted proteins can make whole-body imaging more sensitive owing to reduced absorption
189 omputed tomography allows quantitative whole-body imaging of (111)In-oxine-labeled CTLs at tumor site
190 ity and 45-cm axial field of view, for total-body imaging of (89)Zr-labeled antibodies in rhesus monk
192 ith the exception of liver metastases, whole-body imaging of ER expression with (18)F-FES PET can be
193 sed imaging technology can be used for whole-body imaging of fluorescent cells on essentially all org
194 taneous recurrence (TxN2bM0) underwent whole-body imaging of glucose metabolism with fluorodeoxygluco
195 to engineer mouse melanoma models for whole-body imaging of metastasis generated by human cells, cli
197 n offers the potential for noninvasive whole-body imaging of numerous cellular and molecular processe
198 nts; demonstrated here is MALDI-IMS-MS whole body imaging of rats dosed at 6 mg/kg i.v. with an antic
203 objectives"), is used for three-color whole-body imaging of the two-color cancer cells interacting w
204 (PET) reporter genes allow noninvasive whole-body imaging of transplanted cells by detection with rad
205 dvantage of to develop a technology of whole-body imaging of tumors and gene expression in mouse inte
206 On many indices of disordered eating and body image, older women with eating disorder resemble yo
207 l and Social Function, Role Functioning, and Body Image on EORTC QLQ-C30/QLQ-CR38 analysis and Mobili
211 increased by a factor of about 40 for total-body imaging or a factor of about 4-5 for imaging a sing
212 Healthy volunteers underwent serial whole-body imaging over an approximately 3-h interval, and org
214 The impact of SPLC on improving cosmesis, body image, pain, and QoL has not been evaluated in doub
216 and on previous observations suggesting that body-image pathology is associated with illicit use of a
220 rences exist within racial groups concerning body image perception in relation to overweight status a
223 ment, time since treatment, poor self esteem/body image, physical symptoms, poor performance status,
224 g superior short- and long-term cosmetic and body image, postoperative pain, and QoL in SPLC compared
226 ly after diagnosis; relationship, sexual, or body image problems after diagnosis; and coping strategi
227 d after diagnosis; relationship, sexual, and body image problems; coping strategies; and feelings of
228 hnique, PSMA PET represents a reliable whole-body imaging procedure in combination with second-line t
230 ope distribution using (18)F-FDG and a whole-body imaging protocol to demonstrate proof-of-principle.
231 sttransplant, patient and team expectations, body image, psychiatric complications, functional goals
233 Metabolic Disorders, Volume Analysis, Whole-Body Imaging, Quantification, Supervised Learning, Convo
234 68)Ga-PSMA uptake was quantified using rigid-body image registration of (68)Ga-PSMA PET/CT and interv
237 nation and allogeneic graft rejection, whole body imaging reveals that RA signaling is temporally and
238 luation Subscale (AES) score (range, 1-5), a Body Image Satisfaction (BIS) score (range, 2-11), and r
241 nt Outcome Scale); body image and sexuality (Body Image Scale); and perceived risk of invasive breast
242 s Core 30 and Breast Cancer-Specific Module, Body Image Scale, protocol-specific items, and the Hospi
246 ous flaps had significantly greater gains in body image scores (P = 0.003 and P = 0.034, respectively
247 sis identified 9 themes: Bonding/Attachment; Body Image; Self Esteem/Confidence; Female Role Models;
248 d data regarding the usefulness of brain and body imaging, serum and cerebrospinal fluid (CSF) studie
249 E) on menopausal symptoms (primary outcome), body image, sexual functioning, psychological well-being
250 to assess contentment with quality of life, body image, sexual satisfaction, breast cancer concern,
252 rk Skin versus the Short-Form-12, PVC Metra, Body Image States Scale, and Daily Life Quality Index as
254 ed Imaging, Neural Networks, Oncology, Whole-Body Imaging, Supervised Learning, MR-Functional Imaging
255 hted MRI, Pediatric, Sarcoma, Staging, Whole-Body Imaging Supplemental material is available for this
257 ositron emission tomography (PET) is a whole-body imaging technique using 18 fluorine-fluorodeoxygluc
258 n/Diagnosis, Lymphoma, Tumor Response, Whole-Body Imaging, Technology AssessmentClinical trial regist
259 reast radiotherapy was associated with worse body image than hypofractionated whole breast radiothera
260 st devised by the authors, the men chose the body image that they felt represented 1) their own body,
261 able (vaginal dryness, emotional well-being, body image, the quality of the partnered relationship, a
262 ification of PD-L1 through noninvasive whole-body imaging, thereby enhancing patient stratification.
264 applications, enabling the noninvasive whole-body imaging to localize disease and identification of t
265 hy but was obvious on post-therapeutic whole-body imaging, underscoring the value of post-therapy ima
269 period of thyroid hormone withdrawal, whole-body imaging was performed approximately 24 and 72-96 h
273 and confocal microscopy, together with whole-body imaging, we measured tumor growth delay, survival r
274 CD4 T-cell precursor enumeration, and whole-body imaging, we report that DO affects the repertoire o
277 biodistribution and dosimetry, serial whole-body images were acquired immediately after injection an
281 inistered as an intravenous bolus, and whole-body images were obtained at 30 min, 4 h, and (for the f
284 multaneous anterior and posterior view whole-body images were obtained under identical scan settings
290 esonance (MR) imaging and fluorescence whole body imaging, which respectively tracked iron oxide part
291 uclide bone scan, chest radiograph, or other body imaging, which was performed at the time of biochem
292 Forty patients underwent baseline whole-body imaging with 99mTc-sulfur colloid and evaluation of
293 f non-small cell lung cancer underwent whole-body imaging with a sequential trimodality PET/CT/MR sys
294 ng of oncologic malignancies underwent whole-body imaging with a sequential trimodality PET/CT/MR sys
297 nd biological behavior of NIR-II dyes, whole body imaging with NIR-II dyes for cancer detection and s
298 imaging could provide both noninvasive whole-body imaging with organ-level biodistribution and fluore
299 study of 62Cu-PTSM was performed using whole-body imaging with PET in 10 healthy volunteers and with